Historical Stock Chart
1 Month : From Jan 2020 to Feb 2020
By Dave Sebastian
Merck & Co. (MRK) on Monday said the U.S. Food and Drug Administration has approved its new drug application for Dificid tablets to treat Clostridioides difficile-associated diarrhea in children aged six months and older.
The approval was based on the company's phase 3 study that involved 148 patients, Merck said.
Shares of Merck fell 0.73% in premarket trading.
Write to Dave Sebastian at firstname.lastname@example.org
(END) Dow Jones Newswires
January 27, 2020 07:17 ET (12:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.